news Combatting T-cell tumours with antibody drug conjugates 4 April 2024 | By Drug Target Review One treatment with the anti-TRBC1-SG3249 ADC combination saw cancer elimination within seven days in mouse models.
article Thriving biotech: three stocks building momentum 20 December 2021 | By Dmytro Spilka (Solvid) In this article, Dmytro Spilka explores three promising biotechs that have seen growth in the last year and why they may continue to garner interest.